risperidone has been researched along with oxytocin in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 6 (85.71) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Bundzikova, J; Kiss, A; Mikkelsen, JD; Pirnik, Z | 1 |
| Chadman, KK; Guariglia, SR; Yoo, JH | 1 |
| Yui, K | 1 |
| Eisenstein, M | 1 |
| Akhondzadeh, S; Ashrafi, M; Ghaleiha, A; Hosseini, SM; Jafarinia, M; Modabbernia, A; Rezaei, F; Salehi, B; Tabrizi, M; Tajdini, M | 1 |
| Arango, C; Bighelli, I; Ceraso, A; Charman, T; Çıray, O; Deste, G; Fraguas, D; Huhn, M; Krause, M; Leucht, S; Mavridis, D; Murphy, DG; Parellada, M; Rodolico, A; San José Cáceres, A; Schneider-Thoma, J; Siafis, S; Wu, H | 1 |
3 review(s) available for risperidone and oxytocin
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
New directions in the treatment of autism spectrum disorders from animal model research.
Topics: Adolescent; Adolescent Behavior; Animals; Antipsychotic Agents; Aripiprazole; Brain; Central Nervous System Stimulants; Child; Child Behavior; Child Development Disorders, Pervasive; Child, Preschool; Disease Models, Animal; Dopamine Antagonists; Dopamine Uptake Inhibitors; Drug Discovery; GluK2 Kainate Receptor; Glutamic Acid; Humans; Methylphenidate; Mice; Mice, Inbred C57BL; Oxytocin; Piperazines; Quinolones; Rats; Receptors, Kainic Acid; Risperidone; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists | 2012 |
Pharmacological and dietary-supplement treatments for autism spectrum disorder: a systematic review and network meta-analysis.
Topics: Adolescent; Adult; Attention Deficit Disorder with Hyperactivity; Autism Spectrum Disorder; Child; Humans; Network Meta-Analysis; Oxytocin; Risperidone | 2022 |
1 trial(s) available for risperidone and oxytocin
| Article | Year |
|---|---|
Intranasal oxytocin as an adjunct to risperidone in patients with schizophrenia : an 8-week, randomized, double-blind, placebo-controlled study.
Topics: Administration, Intranasal; Adolescent; Adult; Antipsychotic Agents; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Iran; Male; Middle Aged; Oxytocin; Pilot Projects; Psychiatric Status Rating Scales; Risperidone; Schizophrenia; Schizophrenic Psychology; Severity of Illness Index; Time Factors; Treatment Outcome; Young Adult | 2013 |
3 other study(ies) available for risperidone and oxytocin
| Article | Year |
|---|---|
Different antipsychotics elicit different effects on magnocellular oxytocinergic and vasopressinergic neurons as revealed by Fos immunohistochemistry.
Topics: Animals; Antipsychotic Agents; Benzodiazepines; Clozapine; Haloperidol; Hypothalamus; Immunohistochemistry; Male; Neurons; Olanzapine; Oxytocin; Paraventricular Hypothalamic Nucleus; Proto-Oncogene Proteins c-fos; Rats; Rats, Wistar; Risperidone; Supraoptic Nucleus; Vasopressins | 2010 |
[Useful pharmacologic treatment in impaired social interaction in autism spectrum disorders].
Topics: Administration, Inhalation; Antipsychotic Agents; Arachidonic Acid; Aripiprazole; Child Development Disorders, Pervasive; Child, Preschool; Humans; Interpersonal Relations; Oxytocin; Piperazines; Quinolones; Risperidone | 2012 |
Treatments: In the waiting room.
Topics: Adolescent; Adult; Animals; Aripiprazole; Autistic Disorder; Brain; Child; Clinical Trials as Topic; Drug Approval; Drug Repositioning; Humans; Oxytocin; Piperazines; Quinolones; Risperidone; Selective Serotonin Reuptake Inhibitors; Trichuris; United States; United States Food and Drug Administration | 2012 |